Patents by Inventor Herta CRAUWELS

Herta CRAUWELS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING HIV
    Publication number: 20240139186
    Abstract: The disclosure is directed to the use of rilpivirine, or a salt thereof, to treat HIV infection in pediatric subjects.
    Type: Application
    Filed: January 10, 2024
    Publication date: May 2, 2024
    Inventors: Herta Crauwels, Simon Vanveggel, Veerle Van Eygen
  • REGIMENS FOR TREATING HIV INFECTIONS AND AIDS
    Publication number: 20230120910
    Abstract: A method of treating HIV comprising intramuscular administration once every 4 weeks or less frequently of a combination of cabotegravir or a pharmaceutically acceptable salt thereof and rilpivirine or a pharmaceutically acceptable salt thereof, including the option of discontinuing administration of a first oral anti-retroviral regimen and intramuscularly administering, once four weeks or less often said combination of cabotegravir and rilpivirine.
    Type: Application
    Filed: December 22, 2022
    Publication date: April 20, 2023
    Inventors: Herta CRAUWELS, David Margolis, William R. Spreen, Andrew Spaltenstein, Peter Williams
  • Regimens for treating HIV infections and AIDS
    Patent number: 11564921
    Abstract: A method of treating HIV comprising intramuscular administration once every 4 weeks or less frequently of a combination of cabotegravir or a pharmaceutically acceptable salt thereof and rilpivirine or a pharmaceutically acceptable salt thereof, including the option of discontinuing administration of a first oral anti-retroviral regimen and intramuscularly administering, once four weeks or less often said combination of cabotegravir and rilpivirine.
    Type: Grant
    Filed: July 18, 2018
    Date of Patent: January 31, 2023
    Assignees: ViiV Healthcare Company, Janssen Sciences Ireland Unlimited Company
    Inventors: Herta Crauwels, David Margolis, William R. Spreen, Andrew Spaltenstein, Peter Williams
  • METHODS OF TREATING HIV IN PEDIATRIC PATIENTS WITH RILPIVIRINE
    Publication number: 20220313693
    Abstract: The disclosure is directed to the use of rilpivirine, or a salt thereof, to treat HIV infection in pediatric subjects.
    Type: Application
    Filed: July 3, 2020
    Publication date: October 6, 2022
    Inventors: Herta CRAUWELS, Simon VANVEGGEL, Veerie VAN EYGEN
  • METHODS OF TREATING HIV
    Publication number: 20210000823
    Abstract: The disclosure is directed to the use of rilpivirine, or a salt thereof, to treat HIV infection in pediatric subjects.
    Type: Application
    Filed: July 2, 2020
    Publication date: January 7, 2021
    Inventors: Herta Crauwels, Simon Vanveggel, Veerle Van Eygen
  • REGIMENS FOR TREATING HIV INFECTIONS AND AIDS
    Publication number: 20200147079
    Abstract: A method of treating HIV comprising intramuscular administration once every 4 weeks or less frequently of a combination of cabotegravir or a pharmaceutically acceptable salt thereof and rilpivirine or a pharmaceutically acceptable salt thereof, including the option of discontinuing administration of a first oral anti-retroviral regimen and intramuscularly administering, once four weeks or less often said combination of cabotegravir and rilpivirine.
    Type: Application
    Filed: July 18, 2018
    Publication date: May 14, 2020
    Inventors: Herta CRAUWELS, David MARGOLIS, William R. SPREEN, Andrew SPALTENSTEIN, Peter WILLIAMS